Rifampicin-resistant Mycobacterium tuberculosis: Susceptibility to isoniazid and other anti-tuberculosis drugs

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 3, 2012, Pages 355-357

  Kurbatova, Ekaterina V ^a   Cavanaugh, J S ^a   Shah, N S ^b   Wright, A ^c   Kim, H ^d   Metchock, B ^a   Van Deun, A ^e   Barrera, L ^f   Boulahbal, F ^g   Richter, E ^h   Martin Casabona N ⁱ   Arias, F ^j   Zemanova, I ^k   Drobniewski, F ^l   Santos Silva, A ^m   Coulter, C ⁿ   Lumb, R ^o   Cegielski, J P ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Korean Institute of Tuberculosis   (South Korea)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Argentina)

^g Institut Pasteur d'Algerie   (Algeria)

^h National Reference Center for Mycobacteria   (Germany)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j Institute of Public Health of Chile   (Chile)

^k NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^l PUBLIC HEALTH ENGLAND   (United Kingdom)

^m NATIONAL INSTITUTE OF HEALTH   (Portugal)

ⁿ Queensland Mycobacterium Reference Laboratory   (Australia)

^o INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

more..

Author keywords

Drug resistance; Molecular diagnostic tests; Rifampicin resistance; Tuberculosis

Indexed keywords

AMINOGLYCOSIDE; AMINOSALICYLIC ACID; CAPREOMYCIN; CYCLOSERINE; DNA; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA DETERMINATION; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTITUBERCULAR AGENTS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; RIFAMPIN; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84863123196     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0542     Document Type: Article

References (10)

1. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1115.
2. World Health Organization. Anti-tuberculosis drug resistance in the world. 4th global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
3. Bhanot N. Rapid molecular detection of tuberculosis. N Engl J Med 2011; 364: 183; author reply 4-5.
4. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. 3rd global report. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004.
5. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Antit uberculosis Drug Resistance Surveillance 1994-1997. Geneva, Switzerland: WHO, 1997.
6. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report no. 2: Prevalence and trends. WHO/CDS/TB/2000/278. Geneva, Switzerland: WHO, 2000.
7. Smith S E, Kurbatova E V, Cavanaugh J S, Cegielski J P. Global isoniazid resistance patterns in rifampin-resistant and rifampinsusceptible tuberculosis. Int J Tuberc Lung Dis 2012; 16: 203-205.
8. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
9. Shah N S, Wright A, Bai G H, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2007; 13: 380-387. (Pubitemid 46348124)
10. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet 1999; 353: 1843-1847. (Pubitemid 29251017)